CD28 and colorectal carcinoma: Additionally, According to the study, analyses of human CRC immune profiles and tumor-immune cell interactions revealed that EVs containing miR-424 suppressed the CD28-CD80/86 costimulatory pathway in tumor-infiltrating T cells and dendritic cells, leading to immune checkpoint blockade resistance.